Navigation Links
Genzyme acquistion of Bone Care approved, significant impact forecast

Madison, Wis. - One of Wisconsin's most prominent pharmaceutical companies has been purchased, its stock delisted and its name changed. This move will result in a continued limited presence in Wisconsin, but could also create potential opportunites for the state's life science industry, increase distribution of their drug and has returned significant cash for the firm's investors.

......

Full article >>> company, those Bone Care employees not retained by Genzyme will be offered severance and outplacement assistance to help them transition to new employment.

Quinn said that while the company hopes to keep more than half of the existing staff - mostly in the sales and quality control divisions - executive positions will likely be offered severance packages.

"Since a lot of those po......

Full article >>> d the deals are usually successful for both parties. If a company as successful as Bone Care is purchased in Wisconsin it may help to draw more interest to the state, and having a large company like Genzyme holding office in the state could also help the industry get more momentum.

"The bottom line is we're hopeful the employee base remains in Dane County, but we're not in despair because......

Full article >>> hink this will set them up well for when they finally get a label for Renagel in the pre-dialysis market," Raymond said.......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 07/01/05


Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Emerging technology companies receive significant funding
4. Proposed telecom bill would have Katrina impact
5. Shades of gray: Business impacts of an aging workforce
6. Javas undeniable impact on the Web
7. The flattening world and its impact on U.S. biotech
8. Doyle signs bill that impacts electronic medical records
9. RFID starting to make real impact on business
10. Transition continues to impact Third Wave financials
11. The impact of ACT 255 on the future of high-tech investment in Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... medical technologies, services and solutions to the healthcare market. The company's primary focus ... distribution, manufacturing, sales and marketing strategies that are necessary to help companies efficiently ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):